Insmed Inc – ‘8-K’ for 3/20/01

On:  Thursday, 3/22/01, at 1:22pm ET   ·   For:  3/20/01   ·   Accession #:  916641-1-382   ·   File #:  0-30739

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4     10K 
 2: EX-99.1     Press Release                                          3     12K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION  
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) 
of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 20, 2001

INSMED INCORPORATED 
(Exact name of registrant as specified in its charter)

                                                                [Download Table]


            VIRGINIA                      0-30739                    54-1972729     
----------------------------------------------------------------------------------- 
                                                                                    
(State or other jurisdiction of    (Commission File Number)       (I.R.S. Employer  
         incorporation)                                          Identification No.)

800 East Leigh Street, Richmond, VA 23219 
(Address of principal executive offices and zip code) 

Registrant's telephone number, including area code: (804) 828-6893

8-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.  OTHER EVENTS                                                           

On March 20, 2001, Insmed Incorporated issued a press release 
    announcing the results following a full analysis of its previously
  reported Phase II trial of SomatoKine(R) in patients with Type 2
     diabetes. A copy of the press release is attached hereto as Exhibit
     99.1 and is incorporated herein by reference. The press release was
also posted on Insmed's website on March 20, 2001.            

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS     

(c)      Exhibit                                                                

99.1  Press Release dated March 20, 2001.                     

8-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES

  Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the        
undersigned hereunto duly authorized.                                           

                 INSMED INCORPORATED

Date: March 21, 2001                   By: /s/ Michael D. Baer                  
                                     -------------------------------
                     Michael D. Baer
                             Chief Financial Officer

8-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
INSMED INCORPORATED 
INDEX TO EXHIBITS 

Exhibit Number                                                                  

99.1  Press Release dated March 20, 2001.                                       

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on:		3/22/01							10-K
		3/21/01		3
For Period End:		3/20/01		1		4
									List all Filings